No price relief for Cancer patients as NPPA list shows no change in key drug MRPs

Cancer drug prices remain unchanged from November 9, 2026, with Keytruda at Rs 2.16 lakh and Alecensa at Rs 4.3 lakh, despite trade margin regulations.

Leave a Reply